RCE Charts, page-1424

First 1424 Last

Share
Profile

Follow
BelowAverage

982 Posts.

158

12/08/21

08:42

Post #: 55222157
Share

Originally posted by GaiusMarius: ↑

Why I do not own RCE

RCE has great promise and there is a genuine need for new anti-bacterial medications. I have been following RCE for two years and hope their products actually work. However there are several characteristics of the company that I do not agree with and worries me about their long term survival.

Although they claim they are well progressed in developing anti bacterial and anti viral agents, they have yet to publish a paper in a recognised medical or scientific journal.

They are speading their activities too widely. The anti bacterial market is huge, much bigger than the anti viral market, yet when covid arrives they run off and start investigating that area of medicine.

Their main claims to relevance are pre clinical studies from some unnamed laboratory, previously stated as in the USA but lately they do not even mention what country the laboratory is in. They usually do not mention the methodology of the study just the results.

The worst aspect concerning the unnamed laboratory, is that usually when a biotech does studies, they mention it in advance that the study is underway. That allows investors to wait for the results. RCE does not do this. They just announce the results. That means they could have 10 studies going, but they only mention the results of the positive studies.

RCE must improve its transparancy and governance if they are to be regarded a serious biotech company.

Expand

I'm so confused about your comment? Recce, it's scientists, associates and the phase labs chosen are like the who's who of Australian biomedicine?

RCE Price at posting: 89.5¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

BOE

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Clarity confidence – and share price – up on bumper $203M institutional placement

First 1424 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 42.0¢		Change -0.025(5.62%)		Mkt cap ! $121.4M

Open	High	Low	Value	Volume
44.0¢	44.0¢	41.5¢	$45.92K	107.5K

Buyers (Bids)

No.	Vol.	Price($)
1	120	42.0¢

Sellers (Offers)

Price($)	Vol.	No.
43.0¢	1000	1

View Market Depth

No.	Vol.	Price($)
1	120	0.420
1	17172	0.415
1	19894	0.400
2	11696	0.390
2	107000	0.380

Price($)	Vol.	No.
0.430	1000	1
0.435	10819	1
0.440	8669	2
0.450	20976	3
0.460	24304	3

Last trade - 15.59pm 28/07/2025 (20 minute delay)

RCE (ASX) Chart

RCE Charts, page-1424

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Clarity confidence – and share price – up on bumper $203M institutional placement

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

RCE Charts, page-1424

Top Stories

Boss tanks -42% after quietly flagging 'potential challenges' for Honeymoon

ASX Market Close: New week sees local bourse snaps 2-day losing streak | July 28

Monday's HotCopper trends: Boss guidance, Botanix quarterly | July 28

Listen: HotCopper Wire Podcast 019 – Dreaming of the 9,000s

Clarity confidence – and share price – up on bumper $203M institutional placement

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News